Literature DB >> 19635926

Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease.

Renat Shaykhiev1, Anja Krause, Jacqueline Salit, Yael Strulovici-Barel, Ben-Gary Harvey, Timothy P O'Connor, Ronald G Crystal.   

Abstract

When exposed to a specific microenvironment, macrophages acquire either M1- or M2-polarized phenotypes associated with inflammation and tissue remodeling, respectively. Alveolar macrophages (AM) directly interact with environmental stimuli such as cigarette smoke, the major risk factor for chronic obstructive pulmonary disease (COPD), a disease characterized by lung inflammation and remodeling. Transcriptional profiling of AM obtained by bronchoalveolar lavage of 24 healthy nonsmokers, 34 healthy smokers, and 12 COPD smokers was performed to test the hypothesis whether smoking alters AM polarization, resulting in a disease-relevant activation phenotype. The analysis revealed that AM of healthy smokers exhibited a unique polarization pattern characterized by substantial suppression of M1-related inflammatory/immune genes and induction of genes associated with various M2-polarization programs relevant to tissue remodeling and immunoregulation. Such reciprocal changes progressed with the development of COPD, with M1-related gene expression being most dramatically down-regulated (p < 0.0001 vs healthy nonsmokers, p < 0.002 vs healthy smokers). Results were confirmed with TaqMan real-time PCR and flow cytometry. Among progressively down-regulated M1-related genes were those encoding type I chemokines CXCL9, CXCL10, CXCL11, and CCL5. Progressive activation of M2-related program was characterized by induction of tissue remodeling and immunoregulatory genes such as matrix metalloproteinase (MMP)2, MMP7, and adenosine A3 receptor (ADORA3). Principal component analysis revealed that differential expression of polarization-related genes has substantial contribution to global AM phenotypes associated with smoking and COPD. In summary, the data provide transcriptome-based evidence that AM likely contribute to COPD pathogenesis in a noninflammatory manner due to their smoking-induced reprogramming toward M1-deactivated, partially M2-polarized macrophages.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19635926      PMCID: PMC2873685          DOI: 10.4049/jimmunol.0900473

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  87 in total

1.  The many "small COPDs": COPD should be an orphan disease.

Authors:  Stephen I Rennard; Jørgen Vestbo
Journal:  Chest       Date:  2008-09       Impact factor: 9.410

2.  Production of type VI collagen by human macrophages: a new dimension in macrophage functional heterogeneity.

Authors:  Michael Schnoor; Paul Cullen; Julia Lorkowski; Katrin Stolle; Horst Robenek; David Troyer; Jürgen Rauterberg; Stefan Lorkowski
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

Review 3.  Regulatory T cells and immune tolerance.

Authors:  Shimon Sakaguchi; Tomoyuki Yamaguchi; Takashi Nomura; Masahiro Ono
Journal:  Cell       Date:  2008-05-30       Impact factor: 41.582

4.  Activation of a TGF-beta-specific multistep gene expression program in mature macrophages requires glucocorticoid-mediated surface expression of TGF-beta receptor II.

Authors:  Alexei Gratchev; Julia Kzhyshkowska; Sheila Kannookadan; Miriam Ochsenreiter; Anna Popova; Xiaolei Yu; Srinivas Mamidi; Eugenia Stonehouse-Usselmann; Isabelle Muller-Molinet; Liming Gooi; Sergij Goerdt
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

5.  Decreased cytokine and chemokine mRNA expression in bronchoalveolar lavage in asymptomatic smoking subjects.

Authors:  Anna Meuronen; Marja-Leena Majuri; Harri Alenius; Timo Mäntylä; Henrik Wolff; Päivi Piirilä; Annika Laitinen
Journal:  Respiration       Date:  2008-01-30       Impact factor: 3.580

6.  Unique expression of suppressor of cytokine signaling 3 is essential for classical macrophage activation in rodents in vitro and in vivo.

Authors:  Yu Liu; Keith N Stewart; Eileen Bishop; Carylyn J Marek; David C Kluth; Andrew J Rees; Heather M Wilson
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

7.  Peroxisome proliferator-activated receptor gamma activation promotes infiltration of alternatively activated macrophages into adipose tissue.

Authors:  Rinke Stienstra; Caroline Duval; Shohreh Keshtkar; Jeroen van der Laak; Sander Kersten; Michael Müller
Journal:  J Biol Chem       Date:  2008-06-09       Impact factor: 5.157

8.  Activation of the adenosine-A3 receptor stimulates matrix metalloproteinase-9 secretion by macrophages.

Authors:  Emilie Velot; Benjamin Haas; Frédérique Léonard; Isabelle Ernens; Magali Rolland-Turner; Chantal Schwartz; Dan Longrois; Yvan Devaux; Daniel R Wagner
Journal:  Cardiovasc Res       Date:  2008-07-24       Impact factor: 10.787

9.  Cigarette smoke selectively enhances viral PAMP- and virus-induced pulmonary innate immune and remodeling responses in mice.

Authors:  Min-Jong Kang; Chun Geun Lee; Jae-Young Lee; Charles S Dela Cruz; Zhijian J Chen; Richard Enelow; Jack A Elias
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

10.  Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking.

Authors:  B Barceló; J Pons; J M Ferrer; J Sauleda; A Fuster; A G N Agustí
Journal:  Eur Respir J       Date:  2007-12-05       Impact factor: 16.671

View more
  169 in total

1.  Early macrophage recruitment and alternative activation are critical for the later development of hypoxia-induced pulmonary hypertension.

Authors:  Eleni Vergadi; Mun Seog Chang; Changjin Lee; Olin D Liang; Xianlan Liu; Angeles Fernandez-Gonzalez; S Alex Mitsialis; Stella Kourembanas
Journal:  Circulation       Date:  2011-04-25       Impact factor: 29.690

2.  Coordinated DNA methylation and gene expression changes in smoker alveolar macrophages: specific effects on VEGF receptor 1 expression.

Authors:  Robert A Philibert; Rory A Sears; Linda S Powers; Emma Nash; Thomas Bair; Alicia K Gerke; Ihab Hassan; Christie P Thomas; Thomas J Gross; Martha M Monick
Journal:  J Leukoc Biol       Date:  2012-03-16       Impact factor: 4.962

Review 3.  Sarcoidosis--scientific progress and clinical challenges.

Authors:  Edward S Chen; David R Moller
Journal:  Nat Rev Rheumatol       Date:  2011-07-12       Impact factor: 20.543

Review 4.  Airway Macrophage and Dendritic Cell Subsets in the Resting Human Lung.

Authors:  Vineet Indrajit Patel; Jordan Patrick Metcalf
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

5.  Modulation of Airway Epithelial Innate Immunity and Wound Repair by M(GM-CSF) and M(M-CSF) Macrophages.

Authors:  Sander van Riet; Annemarie van Schadewijk; Steve de Vos; Nick Vandeghinste; Robbert J Rottier; Jan Stolk; Pieter S Hiemstra; Padmini Khedoe
Journal:  J Innate Immun       Date:  2020-04-14       Impact factor: 7.349

6.  Effects of cigarette smoke on Toll-like receptor (TLR) activation of chronic obstructive pulmonary disease (COPD) macrophages.

Authors:  H J Metcalfe; S Lea; D Hughes; R Khalaf; K Abbott-Banner; D Singh
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

7.  Enhancement of COPD biological networks using a web-based collaboration interface.

Authors:  Stephanie Boue; Brett Fields; Julia Hoeng; Jennifer Park; Manuel C Peitsch; Walter K Schlage; Marja Talikka; Ilona Binenbaum; Vladimir Bondarenko; Oleg V Bulgakov; Vera Cherkasova; Norberto Diaz-Diaz; Larisa Fedorova; Svetlana Guryanova; Julia Guzova; Galina Igorevna Koroleva; Elena Kozhemyakina; Rahul Kumar; Noa Lavid; Qingxian Lu; Swapna Menon; Yael Ouliel; Samantha C Peterson; Alexander Prokhorov; Edward Sanders; Sarah Schrier; Golan Schwaitzer Neta; Irina Shvydchenko; Aravind Tallam; Gema Villa-Fombuena; John Wu; Ilya Yudkevich; Mariya Zelikman
Journal:  F1000Res       Date:  2015-01-29

8.  Hepcidin Is Essential for Alveolar Macrophage Function and Is Disrupted by Smoke in a Murine Chronic Obstructive Pulmonary Disease Model.

Authors:  Elizabeth Perez; Jonathan R Baker; Silvana Di Giandomenico; Pouneh Kermani; Jacqueline Parker; Kihwan Kim; Jianjun Yang; Peter J Barnes; Sophie Vaulont; Joseph M Scandura; Louise E Donnelly; Heather Stout-Delgado; Suzanne M Cloonan
Journal:  J Immunol       Date:  2020-09-21       Impact factor: 5.422

Review 9.  Barriers to inhaled gene therapy of obstructive lung diseases: A review.

Authors:  Namho Kim; Gregg A Duncan; Justin Hanes; Jung Soo Suk
Journal:  J Control Release       Date:  2016-05-16       Impact factor: 9.776

Review 10.  Smoking, inflammation and small cell lung cancer: recent developments.

Authors:  Gerhard Hamilton; Barbara Rath
Journal:  Wien Med Wochenschr       Date:  2015-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.